Homebiotech

biotech

biotech

Is atherosclerosis an autoimmune disease?

Jim Cornall - September 10, 2026

biotech

Northway Biotech opens €61m cell therapy and personalised medicine CDMO in Lithuania

Jim Cornall - September 10, 2026

biotech

Eascra Biotech receives NASA contract for space-manufactured nanomedicine

Jim Cornall - September 10, 2026

biotech

Typewriter Therapeutics emerges from stealth with $56m to pursue in vivo CAR T medicines

Jim Cornall - September 9, 2026

biotech

FDA approves lupus nephritis treatment

Jim Cornall - October 20, 2025

biotech

NLS Days winners announced

Jim Cornall - October 20, 2025

biotech

Base to Base biotech podcast 31: Exhilarating enzymes and super socks

Jim Cornall - October 17, 2025

biotech

New company to develop psoriasis monoclonal antibody

Jim Cornall - October 15, 2025

biotech

DNA nanospring could boost disease diagnosis

Jim Cornall - October 15, 2025

biotech

Health Canada approves first treatment for Duchenne muscular dystrophy

Jim Cornall - October 14, 2025

biotech

Neuroblastoma treatment receives Orphan Drug Designation

Jim Cornall - October 13, 2025

biotech

Base to Base biotech podcast 30: Life sciences in Lithuania

Jim Cornall - October 9, 2025

1...676869...99 Page 68 of 99

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Is atherosclerosis an autoimmune disease?

Jim Cornall - September 10, 2026 0

A new study in mice and patients has led to a claim that atherosclerosis meets the criteria for an autoimmune disease. In autoimmune diseases, the...

Northway Biotech opens €61m cell therapy and personalised medicine CDMO in Lithuania

biotech Jim Cornall - September 10, 2026 0

Eascra Biotech receives NASA contract for space-manufactured nanomedicine

biotech Jim Cornall - September 10, 2026 0

Typewriter Therapeutics emerges from stealth with $56m to pursue in vivo CAR T medicines

biotech Jim Cornall - September 9, 2026 0

Zifo says CMC bottleneck choking drug pipeline

biotech Jim Cornall - September 9, 2026 0